HEALTH● LOWAug 28 · Aug 28, 2026, 12:18 PM
Amgen, Astra post late-stage trial win for asthma drug Tezspire in swallowing disorder
Seeking Alpha Tech · global
Amgen and Astra have achieved a late-stage trial win for their asthma drug Tezspire in treating a swallowing disorder. This development indicates potential progress in medical treatment for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH33m agoWould YOU eat chicken - fed salmon ? Fish raised on poultry bones and brains could soon be sold in British supermarkets - but sceptics call the idea unnatural and disgusting dailymail.com · United StatesHEALTH52m agoFirst photo of the Pope after his lung operation and in "constant improvement": officiates a mass with his Peruvian secretaryEl MundoHEALTH1h agoEarly Menopause Research and Global Guidance Need Improvementmiragenews.com · United StatesHEALTH1h agoLilly, Pfizer, J&J among winners of EU drug recommendations this monthSeeking Alpha Tech